Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk of second malignancy after cutaneous T-cell lymphoma.

A F Kantor1, R E Curtis, E C Vonderheid

  • 1Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland.

Cancer
|April 15, 1989
PubMed
Summary

Patients with cutaneous T-cell lymphoma (CTCL) have an elevated risk of developing a second primary cancer, particularly lung, colon, and non-Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T-cell lymphoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Same author

Genetic markers associated with progression in early mycosis fungoides.

Journal of the European Academy of Dermatology and Venereology : JEADV·2013
Same author

Toll-like receptor 2, 4, 7 and 9 expression in primary cutaneous CD30+ T-cell lymphoma.

The British journal of dermatology·2009
Same author

Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.

The British journal of dermatology·2009
Same author

Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis.

The British journal of dermatology·2007
Same author

Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.

Leukemia research·2005

Area of Science:

  • Oncology
  • Epidemiology
  • Cancer Research

Background:

  • Cutaneous T-cell lymphoma (CTCL) is a group of malignant diseases affecting T-cells in the skin.
  • Understanding the long-term health risks for CTCL survivors is crucial for comprehensive patient care.

Purpose of the Study:

  • To assess the risk of developing a second primary malignancy in individuals diagnosed with CTCL.
  • To identify specific cancer types that occur more frequently after a CTCL diagnosis.

Main Methods:

  • Population-based follow-up study utilizing data from the Surveillance, Epidemiology and End Results (SEER) program.
  • Analysis of 544 patients diagnosed with CTCL between 1973 and 1983.

Main Results:

  • A significantly elevated relative risk (RR) of 1.7 for second primary cancers was observed in CTCL patients.

Related Experiment Videos

  • Increased risks were noted for lung cancer, colon cancer, and non-Hodgkin's lymphoma.
  • Approximately 6% of CTCL patients developed a second cancer.

    • Conclusions:

    • CTCL survivors face a heightened risk of subsequent malignancies.
    • The observed excess of non-Hodgkin's lymphoma may indicate disease evolution or shared risk factors.
    • Further research is needed to elucidate the underlying immunologic, genetic, viral, and environmental factors contributing to second cancer development in CTCL patients.